vs
CuriosityStream Inc.(CURI)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
CuriosityStream Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.6倍($19.2M vs $11.6M),CuriosityStream Inc.同比增速更快(35.8% vs -21.4%),过去两年CuriosityStream Inc.的营收复合增速更高(26.5% vs -5.4%)
CuriosityStream是来自美国的流媒体订阅点播服务商,主打纪实类影视内容,涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外,该公司还开设了Curiosity纪实线性电视频道,目前已接入FuboTV、Roku频道等多个平台。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
CURI vs STRO — 直观对比
营收规模更大
CURI
是对方的1.6倍
$11.6M
营收增速更快
CURI
高出57.2%
-21.4%
两年增速更快
CURI
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.2M | $11.6M |
| 净利润 | $-3.8M | — |
| 毛利率 | — | — |
| 营业利润率 | -17.6% | — |
| 净利率 | -19.7% | — |
| 营收同比 | 35.8% | -21.4% |
| 净利润同比 | -34.6% | 35.4% |
| 每股收益(稀释后) | $-0.07 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CURI
STRO
| Q4 25 | $19.2M | $11.6M | ||
| Q3 25 | $18.4M | $9.7M | ||
| Q2 25 | $19.0M | $63.7M | ||
| Q1 25 | $15.1M | $17.4M | ||
| Q4 24 | $14.1M | $14.8M | ||
| Q3 24 | $12.6M | $8.5M | ||
| Q2 24 | $12.4M | $25.7M | ||
| Q1 24 | $12.0M | $13.0M |
净利润
CURI
STRO
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-3.7M | $-56.9M | ||
| Q2 25 | $784.0K | $-11.5M | ||
| Q1 25 | $319.0K | $-76.0M | ||
| Q4 24 | $-2.8M | $-72.4M | ||
| Q3 24 | $-3.1M | $-48.8M | ||
| Q2 24 | $-2.0M | $-48.0M | ||
| Q1 24 | $-5.0M | $-58.2M |
营业利润率
CURI
STRO
| Q4 25 | -17.6% | — | ||
| Q3 25 | -24.5% | -499.9% | ||
| Q2 25 | 2.5% | -5.2% | ||
| Q1 25 | 0.5% | -393.8% | ||
| Q4 24 | -27.4% | -440.7% | ||
| Q3 24 | -25.8% | -797.2% | ||
| Q2 24 | -20.6% | -189.4% | ||
| Q1 24 | -30.4% | -435.0% |
净利率
CURI
STRO
| Q4 25 | -19.7% | — | ||
| Q3 25 | -20.4% | -586.6% | ||
| Q2 25 | 4.1% | -18.0% | ||
| Q1 25 | 2.1% | -436.6% | ||
| Q4 24 | -19.9% | -489.2% | ||
| Q3 24 | -24.3% | -572.6% | ||
| Q2 24 | -16.4% | -186.8% | ||
| Q1 24 | -42.0% | -447.5% |
每股收益(稀释后)
CURI
STRO
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.06 | $-0.67 | ||
| Q2 25 | $0.01 | $-0.14 | ||
| Q1 25 | $0.01 | $-0.91 | ||
| Q4 24 | $-0.05 | $-27.63 | ||
| Q3 24 | $-0.06 | $-0.59 | ||
| Q2 24 | $-0.04 | $-0.59 | ||
| Q1 24 | $-0.09 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $27.3M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $41.5M | $-132.5M |
| 总资产 | $75.7M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CURI
STRO
| Q4 25 | $27.3M | $141.4M | ||
| Q3 25 | $27.8M | $167.6M | ||
| Q2 25 | $28.1M | $205.1M | ||
| Q1 25 | $33.4M | $249.0M | ||
| Q4 24 | $32.1M | $316.9M | ||
| Q3 24 | $33.2M | $388.3M | ||
| Q2 24 | $39.5M | $375.6M | ||
| Q1 24 | $38.8M | $267.6M |
股东权益
CURI
STRO
| Q4 25 | $41.5M | $-132.5M | ||
| Q3 25 | $47.2M | $-87.3M | ||
| Q2 25 | $49.8M | $-32.1M | ||
| Q1 25 | $58.1M | $-25.8M | ||
| Q4 24 | $57.8M | $44.6M | ||
| Q3 24 | $62.2M | $111.2M | ||
| Q2 24 | $64.8M | $152.2M | ||
| Q1 24 | $67.0M | $98.0M |
总资产
CURI
STRO
| Q4 25 | $75.7M | $173.8M | ||
| Q3 25 | $74.7M | $209.7M | ||
| Q2 25 | $78.7M | $262.4M | ||
| Q1 25 | $85.3M | $321.4M | ||
| Q4 24 | $86.2M | $387.2M | ||
| Q3 24 | $87.6M | $451.8M | ||
| Q2 24 | $90.9M | $489.0M | ||
| Q1 24 | $94.6M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.0M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $3.9M | — |
| 自由现金流率自由现金流/营收 | 20.5% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CURI
STRO
| Q4 25 | $4.0M | $-177.2M | ||
| Q3 25 | $4.4M | $-38.2M | ||
| Q2 25 | $2.8M | $-44.7M | ||
| Q1 25 | $1.9M | $-67.9M | ||
| Q4 24 | $3.0M | $-71.7M | ||
| Q3 24 | $2.3M | $-64.5M | ||
| Q2 24 | $2.2M | $9.5M | ||
| Q1 24 | $666.0K | $-64.7M |
自由现金流
CURI
STRO
| Q4 25 | $3.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CURI
STRO
| Q4 25 | 20.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CURI
STRO
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
CURI
STRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图